Advanced search
Publication Cover
Current Eye Research Volume 36, 2011 - Issue 9
Submit an article Journal homepage
699
Views
49
CrossRef citations to date
0
Altmetric
Original Article

A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension

Ronald A. SchacharPfizer Inc, San Diego, California, USA and Meeting presentations: Research presented in part at the Annual Meeting of the Association for Research in Vision and Ophthalmology, May 2–6, 2010, Fort Lauderdale, Florida and at the Annual Meeting of the American Academy of Ophthalmology, October 16–19, 2010, Chicago, Illinois.Correspondence[email protected]
,
Susan RaberPfizer Inc, San Diego, California, USA and Meeting presentations: Research presented in part at the Annual Meeting of the Association for Research in Vision and Ophthalmology, May 2–6, 2010, Fort Lauderdale, Florida and at the Annual Meeting of the American Academy of Ophthalmology, October 16–19, 2010, Chicago, Illinois.
,
Rachel CourtneyPfizer Inc, San Diego, California, USA and Meeting presentations: Research presented in part at the Annual Meeting of the Association for Research in Vision and Ophthalmology, May 2–6, 2010, Fort Lauderdale, Florida and at the Annual Meeting of the American Academy of Ophthalmology, October 16–19, 2010, Chicago, Illinois.
&
Min ZhangPfizer Inc, San Diego, California, USA and Meeting presentations: Research presented in part at the Annual Meeting of the Association for Research in Vision and Ophthalmology, May 2–6, 2010, Fort Lauderdale, Florida and at the Annual Meeting of the American Academy of Ophthalmology, October 16–19, 2010, Chicago, Illinois.
Pages 809-817 | Received 09 Nov 2010, Accepted 29 May 2011, Published online: 18 Aug 2011

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.